Additionally, the apoptosis rate of RCC cells was not enhanced in the presence of TGF-β1 demonstrating that the treatment of the RCC cells with exogenous TGF-β1 does not interfere with their growth properties and does not lead to apoptosis or necrosis with their survival (Supplementary Figure 1). This evidence concerns the gene TGFB1 and renal cell carcinoma.